ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
TC BioPharm Holdings PLC

TC BioPharm Holdings PLC (TCBP)

7.59
0.98
(14.83%)
終了 10月6日 5:00AM
7.225
-0.365
(-4.81%)
取引時間後: 8:52AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
7.225
買値
7.22
売値
7.65
出来高
375,641
6.8016 日の範囲 7.75
0.00 52 週間の範囲 0.00
時価総額
前日終値
6.61
始値
7.00
最終取引時間
財務取引量
US$ 2,730,122
VWAP
7.2679
平均取引量 (3 か月)
-
発行済株式数
582,020
配当利回り
-
PER
-0.75
1 株当たり利益 (EPS)
-10.15
歳入
-
純利益
-5.91M

TC BioPharm Holdings PLC について

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

セクター
Coml Physical, Biologcl Resh
業界
Coml Physical, Biologcl Resh
ウェブサイト
本社
Scotland, Gbr
設立
-
TC BioPharm Holdings PLC is listed in the Coml Physical, Biologcl Resh sector of the ナスダック市場 with ticker TCBP. The last closing price for TC BioPharm was US$6.61. Over the last year, TC BioPharm shares have traded in a share price range of US$ 0.00 to US$ 0.00.

TC BioPharm currently has 582,020 shares in issue. The market capitalisation of TC BioPharm is US$3.85 million. TC BioPharm has a price to earnings ratio (PE ratio) of -0.75.

TCBP 最新ニュース

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening PR Newswire EDINBURGH, Scotland, Oct. 3, 2024 TC BioPharm Limited is partnering with...

TCBP Announces Site Opening of Guys and St. Thomas Hospital

TCBP Announces Site Opening of Guys and St. Thomas Hospital PR Newswire EDINBURGH, Scotland, Sept. 25, 2024 Additional London-based clinic to increase enrolment velocityLeading hospital with...

TCBP to Present at the 2024 ThinkEquity Conference in NYC

TCBP to Present at the 2024 ThinkEquity Conference in NYC PR Newswire EDINBURGH, Scotland, Sept. 24, 2024 EDINBURGH, Scotland, Sept. 24, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...

/C O R R E C T I O N -- TC BioPharm/

/C O R R E C T I O N -- TC BioPharm/ PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 In the news release, TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial...

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial PR Newswire EDINBURGH, Scotland, Sept. 12, 2024 No TCB008-related Adverse Events seen in any of the re-start...

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 9, 2024 EDINBURGH, Scotland, Sept. 9, 2024  /PRNewswire/ -- TC BioPharm...

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox PR Newswire EDINBURGH, Scotland, Sept. 6, 2024 EDINBURGH, Scotland, Sept. 6, 2024 /PRNewswire/ -- TC BioPharm...

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire EDINBURGH, Scotland, Sept. 5, 2024 EDINBURGH, Scotland, Sept. 5, 2024 /PRNewswire/ -- TC...

TCBP Announces Dosing of 5 New Patients in ACHIEVE

TCBP Announces Dosing of 5 New Patients in ACHIEVE PR Newswire EDINBURGH, Scotland, Sept. 3, 2024 5 New patients dosed, bringing total to 6 patients dosed in ACHIEVE at higher dose level5...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CHSNChanson International Holding
US$ 11.22
(269.08%)
14.76M
PEVPhoenix Motor Inc
US$ 1.0607
(205.24%)
228.42M
ENTOEntero Therapeutics Inc
US$ 0.60
(72.20%)
10.42M
BENFBeneficient
US$ 1.8914
(58.94%)
108.31M
FORDForward Industries Inc
US$ 5.3254
(52.15%)
18.45M
ADDColor Star Technology Company Ltd
US$ 0.2701
(-39.98%)
15.01M
DUOFangDD Network Group Ltd
US$ 2.53
(-32.89%)
28.52M
ICCTiCoreConnect Inc
US$ 0.4102
(-31.50%)
1.68M
ZENAZenaTech Inc
US$ 3.91
(-29.55%)
213.24k
SPAISafe Pro Group Inc
US$ 1.93
(-25.77%)
239.89k
NVDANVIDIA Corporation
US$ 124.92
(1.68%)
244.46M
PEVPhoenix Motor Inc
US$ 1.0607
(205.24%)
228.42M
SQQQProShares UltraPro Short QQQ
US$ 7.43
(-3.63%)
184.47M
NCNCnoco noco Inc
US$ 0.144
(8.60%)
147.38M
BENFBeneficient
US$ 1.8914
(58.94%)
108.31M

TCBP Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock